Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Sarepta Therapeutics, the bruised ...
Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics, another ...
Oak Hill Bio, a new company backed by RA Capital and other investors, will take on Ultragenyx and Ionis in developing an ...
Emergency departments across America report dramatic increases in serious injuries from e-bikes and e-scooters,” write CHOP’s ...
Even as some medical schools heed health secretary Robert F. Kennedy Jr.’s call for more nutrition education, several told ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Argenx said Monday it would buy ...
Mayne served as director of the FDA’s Center for Food Safety and Applied Nutrition from 2015-2023. I spent nearly a decade leading FDA’s Center for Food Safety and Applied Nutrition. That role ...
WASHINGTON — A Food and Drug Administration advisory panel recommended on Friday that compounding pharmacies be allowed to ...
The number of measles cases in the U.S. has surpassed the record-breaking tally for all of 2025, with five more months of ...
Today, a win for RFK Jr., as an FDA panel narrowly voted in favor of allowing compounding pharmacies to produce certain ...
In a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results